RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Apex Biotechnology Stock

Apex Biotechnology ROA 2024

Apex Biotechnology ROA

0.05

Ticker

1733.TW

ISIN

TW0001733004

In 2024, Apex Biotechnology's return on assets (ROA) was 0.05, a -30.27% increase from the 0.07 ROA in the previous year.

Apex Biotechnology Aktienanalyse

What does Apex Biotechnology do?

Apex Biotechnology Corp is a Taiwan-based company specializing in the development of innovative biotechnology products. The company was founded in 2002 and offers a wide range of products and services to its customers. Apex Biotechnology Corp began with the production of specialty chemicals and enzymes for research and development purposes. Over the years, the company has expanded its business and focused on the development of diagnostic products, dietary supplements, and pharmaceutical products. The company's business model focuses on the development and marketing of biotechnology products. Apex Biotechnology Corp has established advanced research centers and works closely with research institutions and pharmaceutical companies worldwide to develop innovative solutions. The company operates in various sectors, including diagnostics, dietary supplements, and pharmaceuticals. It offers a diverse range of products, including enzyme immunoassays, lateral flow tests, dietary supplements, and pharmaceuticals. Apex Biotechnology Corp has built strong relationships with research institutions and pharmaceutical companies and has successfully marketed its products internationally. Apex Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Apex Biotechnology's Return on Assets (ROA)

Apex Biotechnology's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Apex Biotechnology's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Apex Biotechnology's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Apex Biotechnology’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Apex Biotechnology stock

What is the Return on Assets (ROA) of Apex Biotechnology this year?

The Return on Assets (ROA) of Apex Biotechnology is 0.05 undefined this year.

What was the ROA of Apex Biotechnology compared to the previous year?

The ROA of Apex Biotechnology has increased by -30.27% compared to the previous year.

What consequences do high ROA have for investors of Apex Biotechnology?

A high ROA is advantageous for investors of Apex Biotechnology, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Apex Biotechnology?

A low ROA can be unfavorable for investors of Apex Biotechnology as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Apex Biotechnology affect the company?

An increase in ROA of Apex Biotechnology can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Apex Biotechnology impact the company?

A reduction in the ROA of Apex Biotechnology can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Apex Biotechnology?

Some factors that can influence the ROA of Apex Biotechnology include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Apex Biotechnology important for investors?

The ROA of Apex Biotechnology is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Apex Biotechnology take to improve ROA?

To improve ROA, Apex Biotechnology can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Apex Biotechnology pay?

Over the past 12 months, Apex Biotechnology paid a dividend of 1.4 TWD . This corresponds to a dividend yield of about 4.7 %. For the coming 12 months, Apex Biotechnology is expected to pay a dividend of 1.4 TWD.

What is the dividend yield of Apex Biotechnology?

The current dividend yield of Apex Biotechnology is 4.7 %.

When does Apex Biotechnology pay dividends?

Apex Biotechnology pays a quarterly dividend. This is distributed in the months of September, July, July, June.

How secure is the dividend of Apex Biotechnology?

Apex Biotechnology paid dividends every year for the past 21 years.

What is the dividend of Apex Biotechnology?

For the upcoming 12 months, dividends amounting to 1.4 TWD are expected. This corresponds to a dividend yield of 4.7 %.

In which sector is Apex Biotechnology located?

Apex Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Apex Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Apex Biotechnology from 6/14/2024 amounting to 1.1 TWD, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.

When did Apex Biotechnology pay the last dividend?

The last dividend was paid out on 6/14/2024.

What was the dividend of Apex Biotechnology in the year 2023?

In the year 2023, Apex Biotechnology distributed 1.3 TWD as dividends.

In which currency does Apex Biotechnology pay out the dividend?

The dividends of Apex Biotechnology are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Apex Biotechnology

Our stock analysis for Apex Biotechnology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Apex Biotechnology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.